Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in MelanomaY.N. Vashisht Gopal, Michael A. Davies, Richard A. Scolyer et al.|Cancer Research|2014Cited by 205
Control of <scp>NF</scp>‐<scp>kB</scp> activity in human melanoma by bromodomain and extra‐terminal protein inhibitor <scp>I</scp>‐<scp>BET</scp>151Stuart Gallagher, Peter Hersey, Branka Mijatov et al.|Pigment Cell & Melanoma Research|2014Cited by 83
Supplementary Figures S1-S12 from Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in MelanomaY.N. Vashisht Gopal, Michael A. Davies, Helen Rizos et al.|Unknown|2023Cited by 0